Profound Medical Corp (PROF) Stock Analysis

Profound Medical Corp (PROF) is a publicly traded company in the HEALTHCARE sector. It trades at $6.48, carries a market capitalization of $242.37M. This page summarizes the public market data, fundamentals, and frequently asked questions for PROF, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Profound Medical Corp currently has a Neutral sentiment score of 0.02.

About Profound Medical Corp

Profound Medical Corp. is a leading Canadian medical technology company headquartered in Mississauga that specializes in developing advanced therapeutic solutions for prostate cancer. The company's flagship TULSA-PRO system uniquely integrates real-time MRI imaging with ultrasound technology, enabling precise targeting of prostate tissue while safeguarding adjacent healthy structures. Committed to enhancing patient outcomes through minimally invasive procedures, Profound is at the forefront o...

GNG Research Analysis

GNG Research scores Profound Medical Corp (PROF) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PROF.

Frequently Asked Questions

Does PROF pay dividends?

Profound Medical Corp (PROF) does not currently pay a regular dividend.

What is PROF's market cap?

Profound Medical Corp (PROF) has a market capitalization of $242.37M with a current stock price of $6.48.